China’s robotic surgical systems is emerging as a dynamic force in the global medical technology landscape, driven by rapid advancements in healthcare innovation and increasing demand for minimally invasive procedures. Against this background, China’s robotic surgical systems market is projected to reach $250 million in 2033, according to GlobalData, a leading data and analytics company.

GlobalData’s Robotic Surgical Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 report reveals that China accounted for around 30% of the Asia-Pacific robotic surgical systems market share in 2023.

Aditi Dakshesh Parikh, Medical Devices Analyst at GlobalData, comments: “The integration of advanced robotics into surgical applications is set to revolutionize medical care by significantly enhancing precision, reducing recovery times, and improving overall patient outcomes. The emphasis on innovation in this field highlights a strong commitment to modernizing the healthcare system, addressing critical challenges, and setting new benchmarks for patient care and surgical excellence.”

A surgical team from Shanghai Chest Hospital has recently performed the first 5G remote robot-assisted lobectomy in the Yangzi Delta region of China. This procedure, using Meihua’s NT-2000 system, facilitated by 3D imaging and 5G technology, was executed within an hour despite the 200-kilometer distance between the surgical team and the patient. This achievement signifies advancements in clinical effectiveness, risk reduction, and rapid recovery.

Parikh concludes: “As robotic technologies mark a transformative moment in the healthcare sector and innovations continue to evolve, it sets new standards for precision and efficiency in medical practices worldwide. This advancement signals a future where China could lead in delivering high-quality, accessible healthcare, driven by cutting-edge technology and reduced reliance on external sources.”